Profile data is unavailable for this security.
About the company
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
- Revenue in USD (TTM)186.63k
- Net income in USD-2.10m
- Incorporated2019
- Employees10.00
- LocationAltamira Therapeutics LtdClarendon House, 2 Church StreetHAMILTON 6300BermudaBMU
- Phone+41 612011350
- Websitehttps://aurismedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Link Reservations Inc | 0.00 | -480.90k | 1.69m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
cbdMD Inc | 20.64m | -23.42m | 1.81m | 52.00 | -- | 0.5982 | -- | 0.0877 | -18.95 | -18.95 | 7.85 | 0.8055 | 0.8817 | 2.01 | 20.35 | 396,856.90 | -82.98 | -38.59 | -112.36 | -41.50 | 63.43 | 63.80 | -94.12 | -87.98 | 0.5172 | -3.89 | 0.3128 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
InVitro International | 716.89k | 6.22k | 2.05m | 16.00 | 257.14 | 2.80 | -- | 2.86 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
Psyence Biomedical Ltd | 0.00 | 1.52m | 2.13m | -- | -- | -- | 1.41 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
SOHM Inc | -100.00bn | -100.00bn | 2.29m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Altamira Therapeutics Ltd | 186.63k | -2.10m | 2.55m | 10.00 | -- | -- | -- | 13.67 | -27.55 | -27.55 | 0.2212 | -0.0746 | 0.0407 | 1.00 | 2.96 | 18,663.44 | -45.74 | -68.57 | -- | -117.99 | -8.39 | -- | -1,124.78 | -26,516.34 | 1.79 | -12.18 | -- | -- | -- | -- | 90.46 | -- | -- | -- |
Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.67m | 40.00 | -- | -- | -- | 0.9666 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
Scorpius Holdings Inc | 9.85m | -29.57m | 2.68m | 82.00 | -- | 0.0165 | -- | 0.2719 | -183.17 | -200.56 | 53.89 | 51.92 | 0.1552 | -- | 11.08 | 120,061.60 | -49.90 | -39.37 | -59.65 | -43.18 | 64.27 | -- | -321.53 | -1,068.21 | 0.3127 | -43.94 | 0.3569 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
Scisparc Ltd | 0.00 | -6.96m | 2.89m | 3.00 | -- | 8.11 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
Healthy Extracts Inc | 2.88m | -1.37m | 3.02m | -- | -- | 7.56 | -- | 1.05 | -0.4725 | -0.4725 | 0.9845 | 0.1336 | 1.12 | 0.6654 | 28.03 | -- | -53.40 | -53.78 | -168.81 | -146.65 | 67.83 | 45.68 | -47.73 | -87.53 | 0.2059 | -0.9153 | 0.7131 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
Aoxing Pharmaceutical Company Inc | 30.11m | -1.46m | 3.21m | 339.00 | -- | 0.0375 | -- | 0.1065 | -0.0192 | -0.0192 | 0.3951 | 0.2507 | 0.496 | 2.32 | 2.56 | -- | -2.41 | -14.54 | -7.06 | -35.45 | 76.19 | 68.51 | -4.85 | -37.69 | 0.7368 | 0.3387 | 0.6052 | -- | 26.88 | 37.20 | -62.49 | -- | -38.80 | -- |
Evoke Pharma Inc | 7.53m | -6.53m | 3.26m | 4.00 | -- | 1.22 | -- | 0.4335 | -16.23 | -16.23 | 11.24 | 3.63 | 0.7128 | 0.4307 | 4.97 | 1,881,428.00 | -61.83 | -100.48 | -136.53 | -151.10 | 96.97 | -- | -86.75 | -480.52 | 1.22 | -19.91 | 0.6523 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
Tonix Pharmaceuticals Holding Corp | 12.46m | -149.01m | 3.30m | 103.00 | -- | 0.035 | -- | 0.2648 | -110.99 | -110.99 | 6.16 | 4.28 | 0.1083 | 0.8436 | -- | 120,951.50 | -129.55 | -59.46 | -157.22 | -65.92 | 21.59 | -- | -1,196.12 | -5,126.73 | 0.7181 | -- | 0.1678 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
Onconetix Inc | 1.46m | -53.12m | 3.44m | 12.00 | -- | -- | -- | 2.35 | -2.62 | -2.62 | 0.0723 | 1.27 | 0.0328 | 3.45 | 5.30 | 121,979.20 | -119.09 | -- | -215.11 | -- | -57.21 | -- | -3,629.24 | -- | 0.091 | -11.87 | 0.2984 | -- | -- | -- | -176.78 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
UBS Securities LLCas of 30 Jun 2024 | 1.71k | 0.08% |
Morgan Stanley & Co. LLCas of 30 Jun 2024 | 933.00 | 0.04% |
Group One Trading LPas of 30 Jun 2024 | 14.00 | 0.00% |
LRI Investments LLCas of 30 Jun 2024 | 1.00 | 0.00% |
Tower Research Capital LLCas of 30 Jun 2024 | 0.00 | 0.00% |